About Redesign Health

This startup focuses on increasing access to early kidney transplants for patients and families affected by kidney disease. They aim to make early transplants a standard treatment option for those living with kidney disease.

```xml <problem> Patients with kidney disease often face challenges in accessing early kidney transplants, which can significantly improve their quality of life and overall outcomes. Systemic hurdles and complexities within the healthcare system can delay or prevent patients from receiving transplants in a timely manner. </problem> <solution> This venture aims to increase access to early kidney transplants by building and scaling transformative healthcare companies focused on addressing the challenges patients and families face when dealing with kidney disease. By leveraging a proven venture-building model and focusing on key areas such as value-based care and data interoperability, the company seeks to streamline the transplant process and improve patient outcomes. The company partners with founders to provide the necessary resources and expertise to navigate the complexities of the healthcare system and accelerate innovation in kidney care. Through this approach, the company strives to make early transplants a standard treatment option for individuals living with kidney disease, ultimately enhancing their lives and well-being. </solution> <features> - Focus on value-based and longitudinal care models to improve patient outcomes. - Emphasis on data interoperability to streamline the transplant process. - Venture-building model to launch and scale transformative healthcare companies. - Partnership with founders to provide resources and expertise. - Focus on expanding access to quality care for patients with kidney disease. </features> <target_audience> The primary target audience includes patients and families affected by kidney disease, as well as healthcare providers and organizations involved in kidney care and transplantation. </target_audience> ```

What does Redesign Health do?

Where is Redesign Health located?

Redesign Health is based in City of New York, United States.

When was Redesign Health founded?

Redesign Health was founded in 2018.

How much funding has Redesign Health raised?

Redesign Health has raised $65.0M.

Who founded Redesign Health?

Redesign Health was founded by Landon Pollack and Matt Weeks.

Landon Pollack - Founder
Matt Weeks - CEO

Location

City of New York, United States

Founded

2018

Funding

$65.0M

Employees

308 employees

Investors

General Catalyst

Redesign Health

City of New York, United StatesFounded 201830850K+ followers10/10 TractionRelative Traction Score based on online presence metrics compared to companies in the same age group.

Updated 15 months ago

Funding

$65.0M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Patients with kidney disease often face challenges in accessing early kidney transplants, which can significantly improve their quality of life and overall outcomes. Systemic hurdles and complexities within the healthcare system can delay or prevent patients from receiving transplants in a timely manner.

Solution

This venture aims to increase access to early kidney transplants by building and scaling transformative healthcare companies focused on addressing the challenges patients and families face when dealing with kidney disease. By leveraging a proven venture-building model and focusing on key areas such as value-based care and data interoperability, the company seeks to streamline the transplant process and improve patient outcomes. The company partners with founders to provide the necessary resources and expertise to navigate the complexities of the healthcare system and accelerate innovation in kidney care. Through this approach, the company strives to make early transplants a standard treatment option for individuals living with kidney disease, ultimately enhancing their lives and well-being.

Target Audience

The primary target audience includes patients and families affected by kidney disease, as well as healthcare providers and organizations involved in kidney care and transplantation.

Features

Focus on value-based and longitudinal care models to improve patient outcomes.
Emphasis on data interoperability to streamline the transplant process.
Venture-building model to launch and scale transformative healthcare companies.
Partnership with founders to provide resources and expertise.
Focus on expanding access to quality care for patients with kidney disease.